Caspase-3 expression in metastatic lymph nodes of esophageal squamous cell carcinoma is prognostic of survival

World Journal of Gastroenterology

Volumn 20, Issue 15, 2014, Pages 4414-4420

  Wang, Xiu Shen ^a   Luo, Kong Jia ^b,c   Bella, Amos Ela ^b,c   Bu, Shan Shan ^a   Wen, Jing ^b,c   Zhang, Shui Shen ^b,c   Hu, Yi ^b,c  

^a ZHENGZHOU UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c Guangdong Lung Cancer Institute   (China)

Author keywords

Caspase 3 protein; Esophageal squamous cell carcinoma; Lymph node; Prognosis

Indexed keywords

CASPASE 3; CISPLATIN; FLUOROURACIL; CASP3 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; DISEASE SPECIFIC SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TISSUE MICROARRAY; DNA MICROARRAY; ENZYMOLOGY; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; KAPLAN MEIER METHOD; LYMPH NODE; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASPASE 3; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84898887544     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i15.4414     Document Type: Article

References (29)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917 [PMID: 21351269 DOI: 10.1002/ijc.25516]
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108 [PMID: 15761078]
3. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300 [PMID: 20610543]
4. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-43 [PMID: 7596430 DOI: 10.1038/376037a0]
5. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994; 124: 619-626 [PMID: 8106557 DOI: 10.1083/jcb.124.4.619]
6. Glinsky GV, Glinsky VV. Apoptosis amd metastasis: a superior resistance of metastatic cancer cells to programmed cell death. Cancer Lett 1996; 101: 43-51 [PMID: 8625281]
7. Takaoka A, Adachi M, Okuda H, Sato S, Yawata A, Hinoda Y, Takayama S, Reed JC, Imai K. Anti-cell death activity promotes pulmonary metastasis of melanoma cells. Oncogene 1997; 14: 2971-2977 [PMID: 9205104 DOI: 10.1038/sj.onc.1201147]
8. Kurabayashi A, Furihata M, Matsumoto M, Ohtsuki Y, Sasaguri S, Ogoshi S. Expression of Bax and apoptosis-related proteins in human esophageal squamous cell carcinoma including dysplasia. Mod Pathol 2001; 14: 741-747 [PMID: 11504832 DOI: 10.1038/modpathol.3880383]
9. Hsia JY, Chen CY, Chen JT, Hsu CP, Shai SE, Yang SS, Chuang CY, Wang PY, Miaw J. Prognostic significance of caspase-3 expression in primary resected esophageal squamous cell carcinoma. Eur J Surg Oncol 2003; 29: 44-48 [PMID: 12559076]
10. Bellini MF, Cury PM, Silva AE. Expression of ki-67 antigen and caspase-3 protein in benign lesions and esophageal carcinoma. Anticancer Res 2010; 30: 2845-2849 [PMID: 20683021]
11. Jiang H, Gong M, Cui Y, Ma K, Chang D, Wang TY. Upregulation of caspase-3 expression in esophageal cancer correlates with favorable prognosis: an immunohistochemical study from a high incidence area in northern China. Dis Esophagus 2010; 23: 487-492 [PMID: 20113321]
12. Poste G, Fidler IJ. The pathogenesis of cancer metastasis. Nature 1980; 283: 139-146 [PMID: 6985715 DOI: 10.1038/283139a0]
13. Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4: 844-847 [PMID: 9662379 DOI: 10.1038/nm0798-844]
14. Gomez-Roca C, Raynaud CM, Penault-Llorca F, Mercier O, Commo F, Morat L, Sabatier L, Dartevelle P, Taranchon E, Besse B, Validire P, Italiano A, Soria JC. Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sites. J Thorac Oncol 2009; 4: 1212-1220 [PMID: 19687761 DOI: 10.1097/JTO.0b013e3181b44321]
15. Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol 2010; 17: 1721-1724 [PMID: 20369299 DOI: 10.1245/s10434-010-1024-1]
16. Fidler IJ, Hart IR. Biological diversity in metastatic neoplasms: origins and implications. Science 1982; 217: 998-1003 [PMID: 7112116 DOI: 10.1126/science.7112116]
17. Weiss L, Holmes JC, Ward PM. Do metastases arise from pre-existing subpopulations of cancer cells? Br J Cancer 1983; 47: 81-89 [PMID: 6571784 DOI: 10.1038/bjc.1983.10]
18. Italiano A, Vandenbos FB, Otto J, Mouroux J, Fontaine D, Marcy PY, Cardot N, Thyss A, Pedeutour F. Comparison of the epidermal growth factor receptor gene and protein in primary non-small-cell-lung cancer and metastatic sites: implications for treatment with EGFR-inhibitors. Ann Oncol 2006; 17: 981-985 [PMID: 16524970]
19. Tsutsui S, Ohno S, Murakami S, Kataoka A, Kinoshita J, Hachitanda Y. EGFR, c-erbB2 and p53 protein in the primary lesions and paired metastatic regional lymph nodes in breast cancer. Eur J Surg Oncol 2002; 28: 383-387 [PMID: 12099646]
20. Italiano A, Saint-Paul MC, Caroli-Bosc FX, François E, Bourgeon A, Benchimol D, Gugenheim J, Michiels JF. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors correlates with EGFR expression in related metastatic sites: biological and clinical implications. Ann Oncol 2005; 16: 1503-1507 [PMID: 15980160]
21. Luo KJ, Hu Y, Wen J, Fu JH. CyclinD1, p53, E-cadherin, and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma: a tissue array analysis. J Surg Oncol 2011; 104: 236-243 [PMID: 21480261 DOI: 10.1002/jso.21921]
22. Sato F, Shimada Y, Watanabe G, Uchida S, Makino T, Imamura M. Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer. Br J Cancer 1999; 80: 1366-1372 [PMID: 10424737 DOI: 10.1038/sj.bjc.6690530]
23. Takayama N, Arima S, Haraoka S, Kotho T, Futami K, Iwashita A. Relationship between the expression of adhesion molecules in primary esophageal squamous cell carcinoma and metastatic lymph nodes. Anticancer Res 2003; 23: 4435-4442 [PMID: 14666731]
24. Cao FM, Zhang XH, Yan X, Wang JL, Xing LX, Wang XL, Shen HT, Wang FR. [Expression and prognostic significance of survivin and caspase-3 in esophageal squamous-cell carcinoma and their relationship with HSPs expression]. Zhonghua Zhongliu Zazhi 2005; 27: 416-419 [PMID: 16188127]
25. Oudejans JJ, Harijadi A, Cillessen SA, Busson P, Tan IB, Dukers DF, Vos W, Hariwiyanto B, Middeldorp J, Meijer CJ. Absence of caspase 3 activation in neoplastic cells of nasopharyngeal carcinoma biopsies predicts rapid fatal outcome. Mod Pathol 2005; 18: 877-885 [PMID: 15803189]
26. Wang LD, Zhou Q, Yang WC, Yang CS. Apoptosis and cell proliferation in esophageal precancerous and cancerous lesions: study of a high-risk population in northern China. Anticancer Res 1999; 19: 369-374 [PMID: 10226569]
27. Fujita J, Crane AM, Souza MK, Dejosez M, Kyba M, Flavell RA, Thomson JA, Zwaka TP. Caspase activity mediates the differentiation of embryonic stem cells. Cell Stem Cell 2008; 2: 595-601 [PMID: 18522852]
28. Janzen V, Fleming HE, Riedt T, Karlsson G, Riese MJ, Lo Celso C, Reynolds G, Milne CD, Paige CJ, Karlsson S, Woo M, Scadden DT. Hematopoietic stem cell responsiveness to exogenous signals is limited by caspase-3. Cell Stem Cell 2008; 2: 584-594 [PMID: 18522851]
29. Abdul-Ghani M, Megeney LA. Rehabilitation of a contract killer: caspase-3 directs stem cell differentiation. Cell Stem Cell 2008; 2: 515-516 [PMID: 18522841]